Penny Stocks News (NYSE, NASDAQ, NYSEMKT)

Find the hidden catayst
Scan all pennies at once

News starting from ticker - A - (default)
PublishedDate (EST) Title
10/23/2017 8:16:48 PM     arca biopharma inc (abio): how does it impact your portfolio?
10/23/2017 7:16:00 PM     cramer remix: the oil market is alive and may be ready to...
10/23/2017 7:01:00 PM     agenus ceo: shingles provides a 'multi-billion-dollar pro...
10/23/2017 6:59:46 PM     cramer remix: the oil market is alive and may be ready to start kicking
10/23/2017 5:51:52 PM     sébastien desprez joins adaptimmune as vice president of communications and investor relations
10/23/2017 5:19:39 PM     HOT !!:pomerantz law firm announces the filing of a class action against antares pharma, inc. and certain officers – atrs
10/23/2017 4:30:00 PM     arrowhead pharmaceuticals reports inducement grants under nasdaq marketplace rule 5635(c)(4)
10/23/2017 2:06:10 PM     mining shares’ directional move in october
10/23/2017 12:06:00 PM     why agenus inc. stock briefly popped today
10/23/2017 11:26:00 AM     bruno lucidi appointed chief executive officer of agentus therapeutics, the cell therapy subsidiary of agenus
10/23/2017 10:19:16 AM     etfs with exposure to amarin corp. plc : october 23, 2017
10/23/2017 9:00:01 AM     the week ahead: earnings season starts in earnest
10/23/2017 9:00:00 AM     HOT !!:amedica announces podium presentations and participation at nass 2017
10/23/2017 8:31:41 AM     aurinia pharmaceuticals, inc. breached its 50 day moving average in a bearish manner : auph-us : october 23, 2017
10/23/2017 8:04:29 AM     see what the ihs markit score report has to say about yamana gold inc.
10/23/2017 8:03:00 AM     agenus creates new cell therapy subsidiary named agentus therapeutics
10/23/2017 8:00:00 AM     arrowhead presents promising preclinical data on development of aro-aat for treatment of alpha-1 liver disease at liver meeting® 2017
10/23/2017 8:00:00 AM     HOT !!:atossa genetics to host conference call to announce preliminary results from phase 1 study of oral endoxifen wednesday, october 25, 2017 at 10 am edt
10/23/2017 7:40:13 AM     gold miners and free cash flow upside estimates for 2017
10/23/2017 7:00:00 AM     HOT !!:achillion announces presentation of data from omega-1 phase 2b trial with odalasvir, al-335, and simeprevir (jnj-4178) at the 2017 liver meeting